Skip to main content

Table 2 Baseline Socio-demographic and clinical characteristics in the CAPRISA 002 trials

From: Modelling HIV disease process and progression in seroconversion among South Africa women: using transition-specific parametric multi-state model

Variables Count/Mean (Percentage/SD)
Marital Status, n(%)
 Single/no partner 34(15.5)
 Married/stable partner 174 (79.5)
 Many partners 11 (5.0)
Educational Status, n(%)
  ≤ Grade 8 16 (7.31)
 Grade 9–10 50 (22.8)
  ≥ Grade 11 153 (69.9)
Age Categories, n(%)
 18–20 years 29 (13.2)
 21–39 years 178 (81.3)
 40–59 years 12 (5.5)
BMI Categories, n(%)
 Underweight 5 (2.3)
 Healthy weight 76 (34.9)
 Overweight/Obese 137 (62.8)
Baseline immunologic state, n(%)
  < 200 CD4 cells/mm3 9 (4.1)
 200–349 CD4 cells/mm3 41 (18.7)
 350–499 CD4 cells/mm3 89 (40.6)
  ≥ 500 CD4 cells/mm3 80 (36.5)
Contraceptive use, n(%)
 No 40 (18.3)
 Yes 179 (81.7)
Anaemia, n(%)
 No 208 (95.0)
 Yes 11 (5.0)
TB Co-infection, n(%)
 No 201 (91.8)
 Yes 18 (9.2)
Sex acts under the influence of alcohol, n(%)
 No 197 (90.0)
 Yes 22 (10.0)
Viral load log10copies/ml, Mean (SD) 4.46 (0.85)
Number of transitions between stage, n(%)
 Transition 1: Normal to Mild 447 (26.1)
 Transition 2: Mild to Advance 374 (21.9)
 Transition 3: Advanced to Severe 103 (6.03)
 Transition 4: Severe to Advance 83 (4.9)
 Transition 5: Advance to Mild 318 (18.9)
 Transition 6: Mild to Normal 386 (22.6)